RGS2 and Hypertension: These findings may have implications in the choice of anti-hypertensive medication because, in hypertension patients who harbor Rgs2 mutations that decrease protein expression and/or function, therapies that concurrently target vasoconstrictor and tubular GPCR signaling may be more effective drug of choice than those drugs that only affect one aspect of renal function.